ESR1 and breast carcinoma: Hormonal therapy for those patients with breast cancer expressing the endocrine receptors estrogen and progesterone has been utilized for longer than 30 years with the administration of tamoxifen, a selective estrogen receptor modulator (SERM) and probably the first targeted therapy widely used in cancer treatment2.